Bank of America Corp
Change company Symbol lookup
Select an option...
BAC Bank of America Corp
SU Suncor Energy Inc
USOI Credit Suisse X-Links Crude Oil Shares Covered Call ETNs
GE General Electric Co
HLNE Hamilton Lane Inc
HLI Houlihan Lokey Inc
HIG Hartford Financial Services Group Inc
HIBB Hibbett Sports Inc
HHC Howard Hughes Corp
VPRB VPR Brands LP
Go

Financials : Banks | Large Cap Value
Company profile

Bank of America Corporation is a bank holding company and a financial holding company. The Company is a financial institution, serving individual consumers and others with a range of banking, investing, asset management and other financial and risk management products and services. The Company, through its banking and various non-bank subsidiaries, throughout the United States and in international markets, provides a range of banking and non-bank financial services and products through four business segments: Consumer Banking, which comprises Deposits and Consumer Lending; Global Wealth & Investment Management, which consists of two primary businesses: Merrill Lynch Global Wealth Management and U.S. Trust, Bank of America Private Wealth Management; Global Banking, which provides a range of lending-related products and services; Global Markets, which offers sales and trading services, and All Other, which consists of equity investments, residual expense allocations and other.

Closing Price
$26.11
Day's Change
0.64 (2.51%)
Bid
--
Ask
--
B/A Size
--
Day's High
26.19
Day's Low
25.26
Volume
(Above Average)
Volume:
63,354,498

10-day average volume:
56,075,071
63,354,498

Hemostats Market to Hit USD 5.54 Billion by 2027; Owing to the Increasing Prevalence of Chronic Disease Worldwide, states Fortune Business Insights(TM)

8:21 am ET June 26, 2020 (Globe Newswire) Print

The global hemostats market size is expected to reach USD 5.54 billion by 2027, while exhibiting a CAGR of 6.3% between 2020 and 2027. This is ascribable to factors such as increasing prevalence of chronic disease and growing demand for technologically advanced products. Fortune Business Insights, publish this information in its latest report, titled "Hemostats Market Size, Share & Covid-19 Impact Analysis, By Product (Active Hemostats, Passive Hemostats, Combination Hemostats, and Others), By Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery and Others), By End User (Hospitals & ASCs, Tactical Combat Casualty Care Centers, and Others), and Regional Forecast, 2020-2027." The report mentions that the market was worth USD 3.72 billion in 2019.

Increasing prevalence of chronic diseases such as cardiovascular disease, cancer, accidents, and trauma, among others is surging the demand for surgical procedures across the globe. However, surgical procedures involves the risk of implications such as disruptive bleeding that result in high mortality rate among the population. A hemostat is a type of medical instrument that is effective in controlling the bleeding during several surgical operations. Furthermore, advancement in the product has enabled the surgeons to administer hemostats that control implications within a short span of time.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hemostatic-agents-market-100084

What does the Report Include?

The market report includes a detailed assessment of the various market drivers and restraints, opportunities, and challenges that the market will face during the projected horizon. Furthermore, the report provides comprehensive research into the regional developments of the market, affecting the market growth during the forecast period.

Moreover, the report includes information sourced from the advice of expert professionals from the industry by our research analyst using several research methodologies for the market. The competitive landscape offers further detailed insights into the strategies such as product launches, partnerships, merger and acquisition, and collaborations adopted by the companies to maintain market stronghold between 2019 and 2026.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

To get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/hemostatic-agents-market-100084

Increasing Adoption of Technologically Advanced Products to Spur Demand

Today, technological advancement is propelling the introduction of innovative products that are efficient in achieving hemostasis. In addition to this, these products prove beneficial in reducing the risk of infections, while aiding in lowering down of healthcare costs largely. The several benefits of advanced hemostats is compelling the manufacturers to develop products that have improved features in containing bleeding implications during the surgical procedures. For instance, Baxter introduced TISSEL, a technologically advanced product for the fibrin sealants category that aids in faster recovery and helps to lower down medical costs.

According to Fortune Business Insights, this global market comprises of several small, medium, and large companies that are trying to strengthen their position and making their presence felt. Among the companies, Baxter, Ethicon, and BD (Becton, Dickinson and Company) are dominating the global marketplace owing to innovative product launches and expansion of product offerings. Adoption of strategies such as product launches, merger and acquisition, collaboration, and partnership by the companies is anticipated to drive the market growth in the forthcoming years. Moreover, increasing focus on R&D by the players to seek Government approval for the clinical trials will favor market growth.

For instance, in April 2019, Baxter announced that its latest product offering, FLOSEAL has received the US Food and Drug Administration (US FDA) approval and unveiled the product at the Association of perioperative Registered Nurses (AORN). The company is focusing on R&D to introduce a cluster of products that can be adopted by surgeons during the surgical procedures, while limiting disruptive blood complications.

Quick Buy - Hemostats Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100084

Regional Insights

North America to Remain Dominant: Increasing Adoption of Technologically Advanced Products to Aid Growth

Among the regions, the market in North America is expected to remain dominant and hold the highest global hemostats market revenue during the forecast period. In addition to this, the market was worth USD 1.29 billion in 2019 and is projected to witness growth owing to high adoption of technologically advanced product in the forthcoming years. Furthermore, high demand for surgical procedures in the region will favor market growth. Europe, on the other hand, is expected to be the second-most leading region during the projected horizon. This is ascribable to factors such as strong and favorable healthcare expenditure policies in the region.

The market in Asia-Pacific is likely to witness growth owing to the presence of large pool of patients that require surgical procedures. Moreover, increasing impetus on novel product launches by the companies in the region will aid in the market growth between 2020 and 2027.

List of the Leading Companies Operating in the Hemostats Market are:

-- Baxter

-- Integra LifeSciences Corporation

-- Stryker

-- CryoLife, Inc.

-- Biom'up

-- BD (Becton, Dickinson and Company)

-- Medtronic

-- Johnson & Johnson Services, Inc.

-- Pfizer Inc.

-- Others

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/hemostatic-agents-market-100084

Detailed Table of Content:

-- Introduction

    -- Research Scope

    -- Research Scope

    -- Market Segmentation

    -- Research Methodology

    -- Definitions and Assumptions

    -- Executive Summary

    -- Market Dynamics

      -- Market Drivers

      -- Market Drivers

      -- Market Restraints

      -- Market Opportunities

      -- Key Insights

        -- Epidemiology of Key Diseases, Key Countries, 2019

        -- Epidemiology of Key Diseases, Key Countries, 2019

        -- Key Industry Developments - Mergers, Acquisitions, and Partnerships

        -- New Product Launches

        -- Global Hemostats Market Analysis, Insights and Forecast, 2016-2027

          -- Key Findings / Summary

          -- Key Findings / Summary

          -- Market Analysis, Insights and Forecast - By Product

            -- Active Hemostats

            -- Active Hemostats

            -- Thrombin-based Hemostats

            -- Fibrin Sealants

            -- Passive Hemostats

            -- Plant-based Hemostats

            -- Plant-based Hemostats

            -- Animal-based Hemostats

            -- Others

            -- Combination Hemostats

            -- Others

            -- Market Analysis, Insights and Forecast - By Application

              -- Trauma

              -- Trauma

              -- Cardiovascular Surgery

              -- General Surgery

              -- Plastic Surgery

              -- Orthopedic Surgery

              -- Neurosurgery

              -- Others

              -- Market Analysis, Insights and Forecast - By End User

                -- Hospitals & ASCs

                -- Hospitals & ASCs

                -- Tactical Combat Casualty Care Centers

                -- Others

                -- Market Analysis, Insights and Forecast - By Region

                  -- North America

                  -- North America

                  -- Europe

                  -- Asia Pacific

                  -- Latin America

                  -- Middle East and Africa

                  TOC Continued....!!!

                  Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/hemostatic-agents-market-100084

                  Have a Look at Related Reports:

                  Hemophilia Drugs Market Size, Share and Global Trend By Disease Indication (Hemophilia A, B & C), Therapy Type (Recombinant Therapy, Plasma therapy & Others), Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Geography Forecast till 2025

                  Thrombin Market Size, Share and Global Trend By Product (Bovine Thrombin, Human Thrombin, Recombinant Thrombin), By Dosage Form (Powder Form, Solution Form), By End user (Hospitals, Diagnostics Centers & Clinics, Academics and Research Institutes), and Geography Forecast till 2025

                  Antithrombin Market Size, Share and Global Trend By Application (Therapeutics, Research, Diagnostics & Others), Source (Human, Goat Milk), Dosage Form (Lyophilized, Liquid) & Geography Forecast till 2025

                  Prothrombin Complex Concentrate Market Size, Share and Global Trend By Product Type (3-factor PCC, 4-factor PCC), Application (Congenital and Acquired Coagulation Factor deficiency), End User (Hospitals, Ambulatory Surgical Centers) and Geography Forecast till 2025

                  About Us:

                  Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

                  Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

                  At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

                  Contact Us:

                  Fortune Business Insights(TM) Pvt. Ltd.

                  308, Supreme Headquarters,

                  Survey No. 36, Baner,

                  Pune-Bangalore Highway,

                  Pune - 411045, Maharashtra, India.

                  Phone:

                  US :+1 424 253 0390

                  UK : +44 2071 939123

                  APAC : +91 744 740 1245

                  Email: sales@fortunebusinessinsights.com

                  Fortune Business Insights(TM)

                  LinkedIn | Twitter | Blogs

                  Press Release: https://www.fortunebusinessinsights.com/press-release/hemostatic-agents-market-9025

                  https://ml.globenewswire.com/media/05408ba1-26b1-4fdd-8f48-1af4df373348/small/fbi-logo-tm-png.png

                  comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.